Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?

Peter Karayiannis; Howard C. Thomas

doi:10.1038/ncpgasthep0118

Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?

Peter Karayiannis, Howard C. Thomas

Medical School

Imperial College London

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	138-139
Number of pages	2
Journal	Nature Clinical Practice Gastroenterology and Hepatology
Volume	2
Issue number	3
DOIs	https://doi.org/10.1038/ncpgasthep0118
Publication status	Published - Mar 2005

Keywords

Advanced liver disease
Antiviral therapy
Chronic hepatitis B
Cirrhosis
Lamivudine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/ncpgasthep0118

Cite this

@article{f2d6e16414644a0c9d3f9a73d80a7e8f,

title = "Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?",

keywords = "Advanced liver disease, Antiviral therapy, Chronic hepatitis B, Cirrhosis, Lamivudine",

author = "Peter Karayiannis and Thomas, {Howard C.}",

year = "2005",

month = mar,

doi = "10.1038/ncpgasthep0118",

language = "English",

volume = "2",

pages = "138--139",

journal = "Nature Clinical Practice Gastroenterology and Hepatology",

issn = "1743-4378",